AI-generated summary
This review describes the authors' overview of mucositis management in adults and children receiving stem cell transplant, a common and severe side effect of high-dose treatment. The authors report that guidelines are scarce, with photobiomodulation and palifermin recommended only for oral mucositis, and that research in this setting consists largely of small, single-center studies that do not yet provide sufficient evidence for recommendations.
- Who or what was studied
- Adults and pediatric patients receiving hematopoietic stem cell transplant (HSCT)
- Limits stated in the abstract
- The authors state that the available studies are mostly small, single-center trials that lack sufficient evidence to support recommendations, and that pediatric evidence is particularly limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dose, Photobiomodulation, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.